Nama Insights

Virtus LifeSci Biotech Products ETF (BBP)

Health · Virtus · NYSE

HealthETF
Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund in the Health category. It has $131.53M in assets, an expense ratio of 0.34% and a 0.00% dividend yield. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
Assets under management$131.53M
Expense ratio0.34%
CategoryHealth
Dividend yield0.00%
NAV$104.22
Fund familyVirtus
ExchangeNYSE

Top holdings

The largest positions Virtus LifeSci Biotech Products ETF reports, by weight.

HoldingNameWeight
MRNA Moderna Inc 4.94%
IOVA Iovance Biotherapeutics Inc 4.65%
OMER Omeros Corp 2.79%
VSTM Verastem Inc 2.52%
PGEN Precigen Inc 2.46%
HALO Halozyme Therapeutics Inc 2.04%
ZLAB Zai Lab Ltd ADR Repr 1 Shs 1.98%
RIGL Rigel Pharmaceuticals Inc 1.88%
KNSA Kiniksa Pharmaceuticals International PLC Class A 1.84%
XERS Xeris Biopharma Holdings Inc 1.80%

Other Health ETFs

Explore live BBP data on Nama Insights →